Poland· PL-100388768
Suboxone
A buprenorphin, kombinationen product containing buprenorphini hydrochloridum + naloxoni hydrochloridum dihydricum, registered in Poland by Indivior Europe Limited. The same ATC class is registered in 10 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Buprenorphin, kombinationen is registered in 10 of 19 countries.
Countries holding a registration under ATC N07BC51 (buprenorphin, kombinationen), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 6 of them publish a price we can compare per daily dose
Buprenorphin, kombinationen · ATC N07BC51
10 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Buprenorphini hydrochloridum + Naloxoni hydrochloridum dihydricum
- Manufacturer
- Indivior Europe Limited
- Country
- Poland (PL)
- ATC code
- N07BC51
- ATC class
- Buprenorphin, Kombinationen
- Defined daily dose
- 8 mg, SL
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Buprenorphin, kombinationen in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaSUBOXONEIndivior Europe Limited, Dublin
- CanadaSUBOXONEINDIVIOR UK LIMITED
- United Statesbuprenorphine and naloxoneHikma Pharmaceuticals USA Inc.
- United KingdomBuprenorphine 2mg / Naloxone 500microgram sublingual tablets sugar freeMartindale Pharmaceuticals Ltd
- FinlandBunalictSandoz A/S
- SwedenBunalict 2 mg/0,5 mg Resoriblett, sublingualSandoz A/S
- NetherlandsBunalict 2 mg/0,5 mg, tabletten voor sublinguaal gebruikSandoz B.V.
- SpainBUPRENORFINA/NALOXONA AUROVITAS 2 MG/0,5 MG COMPRIMIDOS SUBLINGUALES EFGAurovitas Spain, S.A.U.
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Bupensan Duo
- Belgium · Libroxar
- Bulgaria · Булнексо
- Cyprus · Libroxar
- Czechia · Bupensanduo, Libroxar
- Germany · Bowielone, Bulnexo
- Denmark · Bunalict, Buprenorphin/Naloxon G.L. Pharma
- Estonia · Bupensanduo
- Spain · Buprenorfina/Naloxona Aurovitas
- Finland · Bunalict, Buprenorphine/Naloxone G.L. Pharma
- France · Buprenorphine / Naloxone Viatris, Buprenorphine/Naloxone Arrow
- United Kingdom (Northern Ireland) · Buprenorphine/Naloxone Ethypharm, Buprenorphine/Naloxone G.L. Pharma
- Greece · Libroxar
- Croatia · Bulnexo, Bunalict
- Hungary · Bulnexo
- Ireland · Bulexin, Buprenorphine/Naloxone Pinewood
- Iceland · Suboxone, Zubsolv
- Italy · Bunamol, Buprenorfina E Naloxone Ethypharm
- Liechtenstein · Suboxone, Zubsolv
- Lithuania · Bupensanduo
- Luxembourg · Libroxar
- Latvia · Bupensanduo
- Malta · Libroxar
- Netherlands · Bunalict, Buprenorfine/Naloxon Viatris
- Norway · Bunalict, Suboxone
- Portugal · Buprenorfina + Naloxona Generis
- Sweden · Bunalict, Buprenorphine/Naloxone G.L. Pharma
- Slovenia · Bulnexo
- Slovakia · Bupensanduo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d6e18acb-7c5e-458b-9fb3-69b50dbda475 GET /v1/drugs/d6e18acb-7c5e-458b-9fb3-69b50dbda475?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki podjęzykowe",
"source": "urpl",
"strength": "16 mg + 4 mg",
"packaging": "Rpw ¦ EU/1/06/359/005 ¦ 122902\n7 tabl.\nRpw ¦ EU/1/06/359/006 ¦ 122903\n28 tabl.",
"substance": "Buprenorphini hydrochloridum 16 mg + Naloxoni hydrochloridum dihydricum 4 mg",
"common_name": "Buprenorphini hydrochloridum + Naloxoni hydrochloridum dihydricum",
"pl_product_id": "100388768",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about buprenorphin, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.